Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Talius Selected for 2025/26 MedTech Global Accelerator

From Talius

By

January 1, 2026

Talius Selected for 2025/26 MedTech Global Accelerator

Talius Selected for 2025/26 MedTech Global Accelerator
Talius has been selected for the 2025/26 MedTech Global Accelerator, delivered by Brisbane Economic Development Agency in partnership with Life Science Nation. The six-month program supports high-potential medical and digital health ventures and culminates at J.P. Morgan Healthcare Week in San Francisco in January 2026. Talius will use the accelerator to engage global investors and partners for its patient-centred health platform.

View original article on talius.com.au

Most Recent

Neil Rimer thinks the AI money is coming back out

Neil Rimer thinks the AI money is coming back out

Neil Rimer, the venture capitalist who co-founded Index Ventures, predicts the historic wealth AI is generating in Silicon Valley will have to be redistributed, voluntarily or involuntarily.

Jul 17, 2026

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks has remade its image into an AI company and has published research on the cost savings of open weight AI models for coding.

Jul 17, 2026

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

The potential deal highlights a growing trend of complex, multi-stage funding rounds that mask true entry prices.

Jul 17, 2026

Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

Ryan Beiermeister, who demonstrated cool analysis in the Founders Fund YouTube series "Mafia," has joined the firm as a partner.

Jul 16, 2026

Similar Posts

Esther and Anne Wojcicki back new healthcare accelerator, fund

Esther and Anne Wojcicki back new healthcare accelerator, fund

Mary Minno launches early-stage startup accelerator program, Treehub, and an early-stage firm, AI Health Fund, aimed at backing startups working at the intersection of healthcare and AI.

Apr 22, 2026

ŌURA Raises Over $900M to Accelerate Global Expansion and Health Innovation

ŌURA Raises Over $900M to Accelerate Global Expansion and Health Innovation

New Round Led by Fidelity Management & Research Company underscores record growth and OURA's leadership in preventive health technology.

Oct 13, 2025

Leantime selected for the RIoT Accelerator Program Cohort XVI

Leantime selected for the RIoT Accelerator Program Cohort XVI

Leantime announced it was one of seven companies selected for RIoT’s Fall XVI accelerator cohort.

Sep 1, 2023

Mental health startup Intellect partners with Asia’s largest private healthcare group

Mental health startup Intellect partners with Asia’s largest private healthcare group

Intellect, the Singapore-based mental health platform that now serves over three million users in 20 countries, is getting ready for a new phase of growth after striking a strategic partnership with IHH Healthcare, Asia’s largest private healthcare group. IHH Healthcare will work with Intellect to develop and customize digital mental health programs for its patients, […]

Mar 14, 2023

Most Recent

Neil Rimer thinks the AI money is coming back out

Neil Rimer thinks the AI money is coming back out

Neil Rimer, the venture capitalist who co-founded Index Ventures, predicts the historic wealth AI is generating in Silicon Valley will have to be redistributed, voluntarily or involuntarily.

Jul 17, 2026

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks has remade its image into an AI company and has published research on the cost savings of open weight AI models for coding.

Jul 17, 2026

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

The potential deal highlights a growing trend of complex, multi-stage funding rounds that mask true entry prices.

Jul 17, 2026

Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

Ryan Beiermeister, who demonstrated cool analysis in the Founders Fund YouTube series "Mafia," has joined the firm as a partner.

Jul 16, 2026

Similar Posts

Esther and Anne Wojcicki back new healthcare accelerator, fund

Esther and Anne Wojcicki back new healthcare accelerator, fund

Mary Minno launches early-stage startup accelerator program, Treehub, and an early-stage firm, AI Health Fund, aimed at backing startups working at the intersection of healthcare and AI.

Apr 22, 2026

ŌURA Raises Over $900M to Accelerate Global Expansion and Health Innovation

ŌURA Raises Over $900M to Accelerate Global Expansion and Health Innovation

New Round Led by Fidelity Management & Research Company underscores record growth and OURA's leadership in preventive health technology.

Oct 13, 2025

Leantime selected for the RIoT Accelerator Program Cohort XVI

Leantime selected for the RIoT Accelerator Program Cohort XVI

Leantime announced it was one of seven companies selected for RIoT’s Fall XVI accelerator cohort.

Sep 1, 2023

Mental health startup Intellect partners with Asia’s largest private healthcare group

Mental health startup Intellect partners with Asia’s largest private healthcare group

Intellect, the Singapore-based mental health platform that now serves over three million users in 20 countries, is getting ready for a new phase of growth after striking a strategic partnership with IHH Healthcare, Asia’s largest private healthcare group. IHH Healthcare will work with Intellect to develop and customize digital mental health programs for its patients, […]

Mar 14, 2023